The New England journal of medicine
-
Editorial Comment
Another piece of the myeloproliferative neoplasms puzzle.
-
Editorial Comment
A new era of podocyte-targeted therapy for proteinuric kidney disease.
-
Editorial Comment
Do pharmacogenetics have a role in the dosing of vitamin K antagonists?